How Peritoneal Dialysis Systems Improve Home-Based Kidney Care
Mitra Industries is a pioneer Medical Devices Manufacturer in Peritoneal Dialysis Systems, champions Continuous Ambulatory Peritoneal Dialysis India and Automated Peritoneal Dialysis India to empower patients with home-based kidney care. These systems utilize the peritoneal membrane as a natural filter, delivering dialysis fluid via a catheter without relying on haemodialysis centres, ideal for India's vast rural populations.
Flexibility of Continuous Ambulatory PD
Continuous Ambulatory Peritoneal
Dialysis India allows patients to perform
exchanges manually 4-5 times daily, regaining independence without rigid
schedules. This reduces hospital visits by 80%, cuts travel costs, and supports
employment and education continuity, especially for children in remote areas.
Mitra's biocompatible solutions minimize peritonitis risks through sterile
connect ology, aligning with PMNDP guidelines for nationwide scalability.
Automation Enhances Compliance
Automated
Peritoneal Dialysis India employs cyclers to deliver precise nightly exchanges,
improving sleep quality and adherence over manual methods. Patients experience
fewer daytime disruptions, higher quality of life scores, and lower dropout
rates—critical amid India's 2.2 lakh annual ESKD cases. Mitra integrates smart
monitoring in its systems, enabling telemedicine for complication alerts,
decongesting overburdened facilities like those in Kerala’s state wide PD
scheme.
Complementing Diagnostic Tools
Endoscopy Report Management Software
from Mitra streamlines pre-dialysis assessments, digitizing reports for PD
catheter placements and comorbidity tracking. This ensures seamless integration
of endoscopy data with PD protocols, optimizing home care outcomes via
AI-driven insights.
Economic and Equity Benefits
Home
PD slashes out-of-pocket expenses by 50% versus HD, with states like Tamil Nadu
and Kerala proving its viability under PM-JAY. Mitra's PD kits support equity,
bridging urban-rural divides and reducing 70-80% dropout risks from access
barriers. Future expansions via NHM financing promise 10% PD penetration,
fostering self-reliance.
By
prioritizing Continuous Ambulatory Peritoneal Dialysis India and Automated
Peritoneal Dialysis India, Mitra Industries transforms kidney care—affordable,
accessible, and patient-centric.
More Resources:


Comments
Post a Comment